Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.19034 | 48 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.40381 | 56 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.11411 | 47 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.01028 | 46 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.0977 | 48 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.29038 | 50 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.18366 | 47 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.09882 | 47 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.084 | 47 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.10267 | 47 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.06712 | 46 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.00342 | 45 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.10318 | 47 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.10278 | 47 |